Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects
Clinical trial NCT03116347 · COMPLETED
Trial details
- NCT number
- NCT03116347
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-30
- Primary completion
- 2021-01-15
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.